Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPA Culture and Maturation Triggers in IVM
NCT03915054Completed
- Sponsor
- My Duc Hospital
- Start
- Apr 2019
- Primary completion
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of amphiregulin in polycystic ovary syndrome (PCOS) and infertility (2 arms), sponsored by My Duc Hospital. Primary endpoints: Meiotic maturation efficiency at 2 days and Number of transferable day 3 embryos at 5 days. Started Apr 2019; status: completed.
02
Drugs
amphiregulin
03
Conditions
polycystic ovary syndrome (PCOS)infertility
Beyond the preview
Go deeper on NCT03915054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03915054.